A B S T R A C T Acute leukopenia occurs in all patients during the first hour of hemodialysis with cellophanemembrane equipment. This transient cytopenia specifically involves granulocytes and monocytes, cells which share plasma membrane reactivity towards activated complement components. The present studies document that complement is activated during exposure of plasma to dialyzer cellophane, and that upon reinfusion of this plasma into the venous circulation, granulocyte and monocyte entrapment in the pulmonary vasculature is induced. During early dialysis, conversion of both C3 and factor B can be demonstrated in plasma as it leaves the dialyzer. Moreover, simple incubation of human plasma with dialyzer cellophane causes conversion of C3 and factor B, accompanied by depletion of total hemolytic complement and C3 but sparing of hemolytic C1. Reinfusion of autologous, cellophane-incubated plasma into rabbits produces selective granulocytopenia and monocytopenia identical to that seen in dialyzed patients. Lungs from such animals reveal striking pulmonary vessel engorgement with granuloThis work was presented in part at
INTRODUCTION
Profound leukopenia limited to granulocytes and monocytes occurs in all patients during the first 2 h of hemodialysis (1-3). Evidence from studies in dialyzed dogs suggests that this leukopenia is the result ofcell sequestration within the pulmonary vasculature (4); the sequestration is transient and is followed by return of the trapped leukocytes to the circulation within 1-2 h, accompanied by a small cohort of younger cells freshly released from the bone marrow storage pool (3). This cytopenia has been documented to occur with all types of cellophane-membrane dialyzers (2), but not with those containing other membranes such as polysulfone (5). Furthermore, if heparinized human plasma is exposed to dialyzer cellophane and then reinfused into humans, it reproduces the acute, transient, and selective leukopenia of hemodialysis (6) . These data implied that one or more plasma factors which are activated by contact with dialyzer cellophane induce pulmonary leukostasis and the consequent leukopenia. The selective involvement of granulocytes and monocytes, cells known to be reactive to activated complement (C) components, suggested to us that C components might be the plasma factors involved. Indeed, The Journal of Clinical Investigation Volume 59 May 1977 -879- 888 879
C5a, C567, and perhaps C3a potently react with granulocytes and monocytes, particularly as chemotaxins (7) (8) (9) . Moreover, C5a alters granulocyte surface charge (10) , and induces release of lysosomal enzymes from cytochalasin B-treated granulocytes (11) . That cellophane, a polysaccharide, might activate C components seemed not unlikely since numerous other polysaccharides, notably zymosan, inulin, and endotoxins, are capable of inducing complement activation, predominantly via the alternative pathway (12, 13) . The present studies demonstrate that dialyzer cellophane is, in fact, capable of inducing plasma complement activation, and that one or more of the low molecular weight-activated components so produced, is probably responsible for the pulmonary leukostasis and peripheral leukopenia seen in dialyzed patients. METHODS Patient studies. Adult patients undergoing routine hemodialysis at the University of Minnesota Hospitals were studied. Dialysis was performed for 4-6 h with disposable single-use, parallel-plate cuprophane equipment (Gambro Lundia, A. B. Gambro, Lund, Sweden.). Circulatory access was gained with Quinton-Scribner (14) or Buselmeier (15) shunts, or arteriovenous fistulae (16) . Anticoagulation within the dialyzer was achieved with low dose heparin infused into its afferent blood line (17) . Blood for automated cells counts (Coulter model S, Coulter Electronics Inc., Hialeah, Fla.), leukocyte differential counts, and preparation of serum for lysozyme assay, was drawn from this afferent line, proximal to the point of heparin infusion.
Serum hemolytic complement assays were performed utilizing the following buffers and reagents: gelatin-Veronal buffer (GVB)l (18), GVB containing 0.15 mM Ca2+ and 0.5 mM Mg2+ (GVBM) (18, 19) , glucose-gelatin-Veronal buffer containing 0.3 mM Ca2+ and 1.0 mM Mg2+ (GGVBM) (19) , and GVB containing 10 mM EDTA (GVB/EDTA) (19) . C/EDTA was prepared by mixing 0.5 ml of guinea pig serum (Cordis Laboratories, Miami, Fla.), 2.5 ml of a 0.2 M aqueous EDTA solution, and 9.5 ml GVB. C1 was prepared by dialysis at 4°C of 10 ml guinea pig serum against phosphate-buffered saline (PBS) (,um, 0.04) containing 0.3 mM Ca2+ and 1.0 mM Mg2+ at pH 7.5 (PBSM) for 4 h, with hourly changes of the 1-liter bath. The dialyzed serum was centrifuged at 10,000 g for 45 min at 9°C and the precipitate was then dissolved in 20 ml PBSM. The remaining coarse precipitate was removed from this Cl preparation by further centrifugation at 2,000 g for 10 min at 0°C. The hemolytic activity of the Cl preparation was measured as site-forming units per milliliter using EAC4 and guinea pig C2 (Cordis Laboratories) in GGVBM. After a 15-min incubation at 30°C, hemolysis was induced by the addition of excess C/EDTA (18, 20) . The activity of various Cl preparations was of the range 1013_-1014 site-forming units/ml. Human C5 through C9 were obtained commercially IAbbreviations used in this paper: EA, antibody-coated sheep erythrocytes; GGVBM, glucose-gelatin-Veronal buffer containing 0.3 mM Ca2+ and 1.0 mM Mg2+; GVB, gelatin-Veronal buffer; GVBM, GVB containing 0.15 mM Ca2+ and 0.5 mM Mg2+; PBS, phosphate-buffered saline; PBSM, PBS containing 0.3 mM Ca2+ and 1.0 mM Mg2+.
(Cordis Laboratories). Sheep erythrocytes (E) were washed in isotonic saline, GVB/EDTA, and GVBM and stored in GVB containing 250 U/ml penicillin and 250 ,ug/ml streptomycin (Gibco Diagnostics, Chagrin Falls, Ohio) at a cell count of 109/ml (19 (18) , Cl levels by the method described above for Cl preparation (20) , and C3 levels by the addition to EAC1,4 of guinea pig C2 and excess of the human complement components C5 through C9 (Cordis Laboratories) (20) . The (22, 23) . 0.2 ml of normal granulocyte suspension (107 cells/ml), prepared by dextran sedimentation of heparinized whole blood, was added to the upper compartment of a Boyden chamber. Cellophane-incubated plasma was diluted to 2% (vol/vol) in Hank's balanced salt solution and 1.6 ml added to the lower compartment, separated from the granulocyte compartment by a filter (Millipore Corp., Bedford, Mass.) with a 3-,um mean pore size. Such a filter is of sufficient pore size to allow granulocyte, but not monocyte chemotaxis. Triplicate chambers were incubated in humidified air at 37°C for 2 h, and the filters were then removed, washed, stained, and their distal sides counted. The chemotactic response was expressed as the number of segmented granulocytes seen in 10 grids/107 granulocytes applied to the upper compartment.
The capacity of cellophane-incubated plasma to induce granulocyte adhesion was measured in an in vitro system. Purified granulocytes were resuspended in the plasma under study. Duplicate 1-ml aliquots of each suspension were added to 10 x 35-mm Petri dishes (Falcon Plastics, Division of BioQuest, Oxnard, Calif.), and incubated for 30 min at 37°C. Nonadherent cells were removed by six washes with isotonic saline and the remaining, adherent granulocytes either counted directly with phase-contrast microscopy, or indirectly by assay of their myeloperoxidase content (24) . Their myeloperoxidase content was expressed as a percentage of total granulocyte myeloperoxidase content initially applied to the Petri dish.
Rabbit studies. Adult New Zealand white rabbits were anesthetized with i.v. sodium pentothal USP, and pyrogenfree cannulae (Intracath, C. R. Bard Inc., Murray Hill, N. J.) were surgically inserted into the femoral vein and the femoral artery as far as the right atrium and aortic arch, respectively. Plasma was prepared, by the method described above, from blood drawn from the aortic cannula, and the unused erythrocytes were reinfused. After incubation with either cellophane or zymosan, and subsequent removal of the activator, the plasma was infused into the femoral vein cannula with a standard Harvard pump (Harvard Apparatus Co., Inc., Millis, Mass.). Automated blood cell counts and 200-cell, leukocyte differential counts were performed in duplicate upon EDTA-anticoagulated samples drawn simultaneously from both aortic and right atrial cannulae. Comparison of such simultaneous granulocyte counts provided an estimate of cell clearance by the pulmonary vasculature. During some plasma infusions, rapid pulmonectomy was performed. The resected lungs were examined by light microscopy after fixation in 10% formalin and staining with hematoxylin and eosin.
Before incubation with cellophane, some rabbit plasmas were heated at 560C for 30 min (25), mixed with EDTA in a final concentration of 10 mM (26), or incubated with 10 mM hydrazine (27) (28) (29) , to inhibit both classical and alternate pathways of the complement cascade. Relatively specific classical pathway inhibition was achieved by the addition of 10 mM ethylene glycol tetraacetic acid (EGTA) containing 10 mM Mg2+ (30) . Complement depletion was induced in vivo by the infusion of Naja-Naja cobra venom factor (CVF) (Ross Allen's Reptile Institute, Inc., Silver Springs, Fla.) purified by DEAE chromatography (31, 32) . CVF activity was assayed against paroxysmal nocturnal hemoglobinuria erythrocytes (33, 23) . Depletion of rabbit complement was induced by two i.v. 400-U CVF/kg injections, 24 h apart (31) . Cellophane-incubated plasma infusion studies were performed in these animals [6] [7] [8] h after the last CVF injection, by which time the leukopenia induced by the CVF had resolved (34) . Cellophane-and zymosan-incubated plasmas were fractionated at 40C with a Sephadex G-200 column (2.5 x 100 cm, void volume 180 ml, and total bed volume 490 ml) using PBS at pH 7.4 containing 0.001% sodium azide (wt/vol). 2 ml of plasma was applied to the column, which had previously been calibrated with blue dextran, human hemoglobin, and cytochrome c, and the fractions eluting after void volume were pooled into eight sequential 50-ml sets. Each set was infused individually into a cannulated rabbit at a 8-ml/min flow rate with 30-min rest periods between each set. The arterial granulocyte count after a 2-min infusion was expressed as a percentage of the arterial count immediately before infusion, so that the approximate molecular weight of the most potent leukopenia-inducing fractions could be defined (35) .
RESULTS
Patient studies. All 34 consecutive patients developed severe, albeit transient neutropenia (P < 0.001, paired t test) and monocytopenia (P < 0.01) during the first 20 min of hemodialysis (Fig. 1) Fig. 3) .
Experiments with human plasma in vitro. Incubation of human plasma with dialyzer cellophane produced a 25% decrement in serum total hemolytic complement, associated with preservation of hemolytic Cl, but a significant decrement in hemolytic C3 (Fig. 4) . Qualitatively similar changes were produced in plasma by incubation with zymosan, although, under the conditions of these experiments, complement depletion was more intense than with cellophane (Fig. 4) (Fig. 5) . The effect of cellophane-incubated plasma was assayed by direct counting of adherent granulocytes (left, Fig. 5 ), and that of zymosan-incubated plasma by myeloperoxidase assay of adherent cells (right, Fig. 5 ). Adhesion was minimized when plasma was heated at 560C for 30 min to inactivate complement, before incubation with cellophane or zymosan (stippled bars, Fig. 5 ).
Rabbit studies. Infusion of autologous, cellophane-incubated rabbit plasma into the vena cava at the rate of 1 ml/min, induced selective monocytopenia (not shown) and neutropenia, but no significant decrement in lymphocyte counts (Fig. 6) . At (Fig. 7a) . Infusion of cellophane-incubated plasma, which had been previously heated at 56°C for 30 min to prevent C activation, produced no leukostasis (Fig. 7b) . In animals infused with active plasma, serum lysozyme levels did not increase during granulocyte and monocyte sequestration. Thus, at the end of a 20-min cellophane-incubated plasma infusion (1 ml/min), the aortic and vena cava serum lysozyme levels were respectively 1.75±0.61 and 1.74±0.54 ,ug/ml, not significantly different from each other or increased above the preinfusion levels of 1.78±0.62 and 1.98 ±0.61 ug/ml. It is therefore unlikely that leukostasis is accompanied by significant lysozyme release. The capacity of dialyzer cellophane to induce plasma activation and subsequent leukopenia was not inhibited by four washes in isotonic saline or distilled water, nor by boiling or incubation with albumin at 37°C for 30 min. When reinfused into rabbits not only did dialyzer cellophane-activated plasma induce neutropenia (solid circles, Fig. 8 ), but infusion of plasma in which C was activated by zymosan incubation also produced similar, albeit more prolonged, decrement in neutrophil counts (open triangles. Fig. 8 ). Addition of 10 mM EDTA to plasma before cellophane incubation prevented neutropenia (squares, Fig. 8 ), whereas 10 mM EGTA/Mg2+ (which preserves alternative pathway activation) was noninhibitory (open circles, Fig. 8 ). Moreover, heated or hydrazine-treated plasmas were separately inactive after cellophane incubation, but if they were mixed before cellophane exposure (thereby reconstituting C3 activatability) neutropenia-inducing activity was regained (not shown). Finally, reinfusion of plasma which had been decomplemented by injecting the donor rabbit with two doses of CVF vas ineable of inducing neutropenia; in contrast complement-replete plasma, collected before the CVF infusions, produced the expected leukopenia both in normal and in CVF-treated rabbits (not shown).
When fractions of cellophane-or zymosan-incubated plasmas were prepared by Sephadex G-200 filtration and reinfused into rabbits, the most marked neutropenia was induced with fractions of the approximate molecular weight range of 7,000-20,000 daltons (eluate volume 420-520 ml, Fig. 9 ). 
DISCUSSION
Hemodialysis has been in clinical use years (36) , but some of its diverse and u complications have only recently becom (37, 38) . The acute leukopenia of hemod described 8 yr ago (1, 2), but its mechani mained obscure (39) . Entrapment of gi within the dialyzer was initially proposei cell kinetic studies demonstrated sequestra the patient's microcirculation (2), which quently confirmed in dialyzed dogs wher was the primary site of accumulation (4). T studies demonstrate that dialyzer cellophar complement during human hemodialyses. from our ancillary studies in rabbits it a] low molecular weight (-7,000-20, Although more rigorous analysis is required, the nsuspected present data suggest that if indeed an activated complee apparent ment product is responsible for the leukopenia/ Lialysis was pulmonary leukostasis phenomena, it has a molecular ism has re-weight in the range of 7,000-20,000 daltons. In ranulocytes similar studies of the neutropenia which results from d (40), but i.v. infusion of CVF, McCall and co-workers were ttion within able to define factor(s) of identical size range as was subse-being responsible for the cytopenia, and postulated re the lung that this factor may be derived from either C3 or C5 'he present (34) . C5a has a molecular weight of 17,000 daltons ie activates (42) , and is able to alter the surface charge of Moreover, granulocyte plasma membranes (10), induce granuloppears that cyte chemotaxis (8) , and release lysosomal enzymes )ns) C com-from cytochalasin B-treated granulocytes (11) . to dialyzer Nevertheless, C3a, with the molecular weight of ranulocytes 9,000 daltons (42), although less potent that C5a, vasculature is probably also able to induce granulocyte chemoCombining taxis (7) (8) (9) , and, on the basis of the present data, canactivated C not be excluded as the factor responsible for is in hemo-leukostasis. epublished Although we suggest that i.v. infusion of such a ostasis pro-factor(s) induces pulmonary leukostasis, it is not ceri in these tain whether granulocyte aggregation, followed by pulmonary embolism of the aggregates, is the pri- (43) . Thus, granulocytE and pulmonary embolization remain a vi; mechanism for hemodialysis pulmonary
The absence of any detectable increase in serum lysozyme during leukostasis in patient or rabbits implies that the complement/granulocyte interaction of dialysis is not accompanied by prominent degranulation. Indeed, if C5a proves to be causal to the leukostasis syndrome, it is noteworthy that this component will only induce appreciable lysosomal enzyme release if granulocytes are first rendered labile with cytochalasin B (11) . 77n The transience of leukopenia during hemodialysis may well result from progressive inability during the procedure of the cellophane membranes to activate complement. It is known that reuse of a 3\q dialyzer will not result in leukopenia unless it is thoroughly rinsed with isotonic saline (44) , suggesting that the cellophane becomes coated with salinesoluble agent(s) which block its activating capacity but not its efficacy as a dialyzer component.
These data not only suggest an explanation for the phenomenon of hemodialysis leukopenia and leukostasis, but may also generate insights into the abnormalities of peripheral granulocyte counts in other no0 clinical situations. For instance, we suggest that the chronic granulocytopenia seen in patients with ongoing complement activation, such as occurs in Felty's syndrome or in systemic lupus erythematosus (45) , may be of similar origin, particularly in those pa-LM, tients with undetectable leukoagglutinins (46) .
